Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain

Purpose: The introduction of direct-acting antivirals (DAAs) has revolutionized the treatment of chronic hepatitis C viral (HCV) infection. This study aims to establish real-world treatment efficacy of Sofosbuvir-based (SOF-B) and Ombitasvir/Paritaprevir/Ritonavir-based (OPR-B) regimens. Patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Maheeba, Ali, Hamed, Nass, Hafsa, Khamis, Jawad, AlQamish, Jehad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524762/
https://www.ncbi.nlm.nih.gov/pubmed/31191049
http://dx.doi.org/10.2147/HMER.S190967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524762/
https://www.ncbi.nlm.nih.gov/pubmed/31191049
http://dx.doi.org/10.2147/HMER.S190967

Ejemplares similares